Oncology
Oncology Vol 29 No 12
Volume: 29
Issue: 12
Oncology Vol 29 No 11
Volume: 29
Issue: 11
Oncology Vol 29 No 10
Volume: 29
Issue: 10
Oncology Vol 29 No 9
Volume: 29
Issue: 9
Oncology Vol 29 No 8
Volume: 29
Issue: 8
Oncology Vol 29 No 7
Volume: 29
Issue: 7
Oncology Vol 29 No 6
Volume: 29
Issue: 6
Oncology Vol 29 No 5
Volume: 29
Issue: 5
Oncology Vol 29 No 4_Suppl_1
Volume: 29
Issue: 4_Suppl_1
Oncology Vol 29 No 4
Volume: 29
Issue: 4
Oncology Vol 29 No 3
Volume: 29
Issue: 3
Oncology Vol 29 No 2
Volume: 29
Issue: 2
Oncology Vol 29 No 1
Volume: 29
Issue: 1
Oncology Vol 28 No 3
Volume: 28
Issue: 3
Oncology Vol 28 No 12
Volume: 28
Issue: 12
Oncology Vol 28 No 11_Suppl_3
Volume: 28
Issue: 11_Suppl_3
Oncology Vol 28 No 11
Volume: 28
Issue: 11
Oncology Vol 28 No 10
Volume: 28
Issue: 10
Oncology Vol 28 No 9
Volume: 28
Issue: 9
Oncology Vol 28 No 8
Volume: 28
Issue: 8
Oncology Vol 28 No 7
Volume: 28
Issue: 7
Oncology Vol 28 No 5_Suppl_2
Volume: 28
Issue: 5_Suppl_2
Oncology Vol 28 No 5
Volume: 28
Issue: 5
Oncology Vol 28 No 4_Suppl_1
Volume: 28
Issue: 4_Suppl_1
Oncology Vol 28 No 1S
Volume: 28
Issue: 1S
Oncology Vol 28 No 1S
Volume: 28
Issue: 1S
Oncology Vol 28 No 6
Volume: 28
Issue: 6
Oncology Vol 28 No 4
Volume: 28
Issue: 4
Oncology Vol 28 No 2
Volume: 28
Issue: 2
Oncology Vol 28 No 1
Volume: 28
Issue: 1
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
Convergent and Divergent Signaling Pathways in Cancer: A Dual-Axis Model for Adaptive Precision Oncology
3
FDA Approves Revumenib in R/R NPM1-Mutant AML
4
ctDNA Status May Determine Adjuvant Immunotherapy Benefit in MIBC
5
